Delivery Order SPE2DB22D2206-SPE2DB25FDU13

Award Date 10/15/24
Potential Completion Date 10/16/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The $16,528.40 firm-fixed-price contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of September 17, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $5,607.17 firm-fixed-price delivery order to Amerisourcebergen Drug Corp for the supply of 4,565,321,019 units of Budesonide-Formoterol 80-4.5 10.2GM, a critical pharmaceutical product. This delivery order is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support military...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Budesonide-Formoterol 160-4.5 10.2GM medical products. The fixed-price contract has a ceiling value of $8,422.79 and an ultimate completion date of January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and DLA Troop Support Medical, which serves as a primary...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $1,515.72, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for 4,568,062,481 units of the medication Budesonide-Formoterol 160-4.5 10.2GM. The contract is a firm fixed-price delivery order with a ceiling value of $1,747.20 and a period of performance through April 29, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued...
The U.S. Defense Logistics Agency (DLA) awarded a $3,619.08 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product Budesonide-Formoterol 160-4.5 10.2GM. This order is part of Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this...
The Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $3,706.60 firm fixed price delivery order contract to provide Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves...
This is a $7,588.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a respiratory medication, with an ultimate completion date of August 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to...
This is a $1,324.50 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a medication used for the treatment of respiratory conditions. The contract has an ultimate completion date of April 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,772,504 units of budesonide-formoterol 160-4.5 10.2GM, a medication used for the treatment of respiratory conditions. The delivery order is valued at $2,620.80 and has a firm fixed price pricing type. The contract has an ultimate completion date of April 3, 2025 and was...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FDU13
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $3,467.47 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to procure 4,566,108,720 units of the pharmaceutical product Budesonide-Formoterol 160-4.5 10.2GM. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently acquire a comprehensive range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract has an ultimate completion date of October 16, 2024 and does not utilize a set-aside designation.

Generated 1/14/25, 9:13 AM